Regulatory Landscape for CAR T-cell Therapy

Get up to date on menin inhibitors, an emerging class of targeted therapies for acute myeloid leukemia (AML). Menin is a key component of the KMT2A (lysine methyltransferase 2A, formerly MLL1) complex, which plays a critical role in gene regulation, development, and cell cycle co ...  Show more

Get up to date with the EHA–ESMO guidelines on Human immunodeficiency virus (HIV)-associated Lymphomas. In this episode, Prof. Kai Hubel, a key author of the guidelines, explains the importance of having dedicated recommendations for patients with HIV-associated lymphomas. He beg ...  Show more

In this episode we explore all things to do with managing patients with Osteoporosis. We cover:

This episode, hosts Sophie Neale and Dr. Tanner Schrank discuss putting that medical school knowledge into practice, focusing on the importance of communication, empathy and strong interpersonal skills when working directly with patients. Exploring this topic from both a physicia ...  Show more

Join Dr. Jerry Yoo as he sits down with Dr. Tom Buchheit, Director of the Regenerative Pain Therapies Program at Duke University. In this episode, Dr. Buchheit shares insights into how regenerative medicine and regenerative physical therapy can potentially spare individuals f ...

This week we delve back into the world of the Fontan to discuss the fate of the liver in the Fontan patient. We speak with hepatologist, Professor Dellys Soler Rodriguez of Emory University about a recent work she published on the fate of the liver in patients following heart-onl ...  Show more